|
The Initiative supports publication in the open access journal Hepatology, Medicine and Policy The journal aims to galvanise the global public health response by providing a forum for researchers, policy-makers, health service providers, members of affected communities and other stakeholders to collectively explore how the greatest health gains can be achieved at the local, national and global levels.
|
|
Previous research:
Publication of the BMC Infectious Desease Journal Supplement 'Viral Hepatitis and Drug Use in Europe´. The publication was produced in the framework of the 'Hepatitis C Initiative' project by CHIP, The Centre for Health and Infectious Disease Research, University of Copenhagen. The publication contains five research articles and a discussion article that collectively demonstrate the potential for smart research to help transform the political and public health response to hepatitis C in Europe and presents no less than ten commentaries about crucial issues in this realm with a broad diversity of experiences represented in the contributions. The full content of the supplement can be found at |
 |
Monitoring of the testing for hepatitis C has been implemented in low-threshold services in Germany, Romania, Portugal and Finland.
The monitoring aimed at collecting data on the proportion of drug users who have been tested for HCV, the prevalence of HCV and the number of drug users that should be tested for hepatitis C. |
|
In the four European countries Finland, Germany, Romania and Portugal a broaderinvestigation on drug use and infections with the hepatitis C virus (HCV) was conducted.
One part of the research consisted in the longitudinal screening of visitors of low-threshold drug services for previous HCV antibody testing and their current HCV testing need. A second part consisted in a survey aimed at exploring the drug users’ experiences with testing and treatment. |
